Illumina Inc. (1ILMN)
MTA
Closed
Oct 2, 2026
Day's Range
241.1052 wk Range
77.12Overview - 1ILMN - Illumina Inc.
Key Statistics
Valuation
Enterprise Value
33.12B
P/E (Trailing)
‪50.08‬
PEG Ratio
‪-6.21‬
Price / Sales (TTM)
‪7.94‬
Price / Book
‪14.41‬
EV / EBITDA
‪32.67‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
149.77M
Held by Insiders
‪0.21%‬
Held by Institutions
‪106.48%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪183.55‬
200-Day Avg
‪137.60‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1ILMN - Illumina Inc.
Peers - 1ILMN - Illumina Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on MTA.
- 1ILMNMTAIllumina Inc.19.52BMarket Cap+63.77%52-week change50.08P/E (Trailing)‪18.33%‬Profit Margin
- 1TMOMTAThermo Fisher Scientific Inc.198.93BMarket Cap+30.70%52-week change36.10P/E (Trailing)‪15.03%‬Profit Margin
- 1DHRMTADanaher Corp.147.02BMarket Cap+19.49%52-week change39.89P/E (Trailing)‪15.94%‬Profit Margin
- 1IDXXMTAIDEXX Laboratories, Inc.45.43BMarket Cap-16.29%52-week change37.23P/E (Trailing)‪25.03%‬Profit Margin
- 1LONNMTALonza Group AG41.03BMarket Cap+7.01%52-week change36.63P/E (Trailing)‪-1.60%‬Profit Margin
- 1IQVMTAIQVIA Holdings Inc.37.62BMarket Cap+28.54%52-week change33.73P/E (Trailing)‪8.09%‬Profit Margin
- 1AMTAAgilent Technologies Inc.35.81BMarket Cap+30.59%52-week change34.45P/E (Trailing)‪19.53%‬Profit Margin
Profile Summary - 1ILMN - Illumina Inc.
About
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
